Erlanger Oncology and Hematology is a clinical research site located in Chattanooga, Tennessee, United States 37403.
Crixeo Clinical Trials Trust Score: 6/100 (FAILING). This profile has not yet been claimed by the site owner.
Erlanger Oncology and Hematology has participated in 2 clinical trials.
Therapeutic areas: Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma Transitional Cell.
Sponsors: Astellas Pharma Global Development, Inc., Seagen Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Chattanooga
Trust Score: 6/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Erlanger Oncology and Hematology has a Crixeo Trust Score of 6/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Erlanger Oncology and Hematology has 2 clinical trials on record. Their work covers Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma Transitional Cell.
Erlanger Oncology and Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.